Effective for stubborn fat in areas that resist diet and exercise chin, jowls, arms, stomach, back, thighs and hips
Retatrutide is an experimental injection developed by the US drugmaker Eli Lilly
Uncommon: chest pain, feeling strange, pyrexia, injection site reaction
Further prospective studies, particularly on long-term users and high-risk surgical populations, may refine recommendations on fasting duration, imaging use, and anaesthetic modifications
Bioabsorbable intracoronary matrix for prevention of ventricular remodeling after myocardial infarction
During treatment, the one-year incidence of events was 1.3% for acute coronary syndromes, 13.2% for coronary artery disease, 7.3% for heart failure, 1.9% for stroke, and 0.06% for all-cause mortality